BioArctic and Novartis sign an option, collaboration and license agreement using BrainTransporter™ for an upfront payment of USD 30 million plus additional potential milestones and royalties
Published on 08/26/2025 at 07:19 | prnewswire.co.uk
en | CH0012005267 | BIOARCTIC | boerse | 68147548 |
